Table 2.
Adverse events during the procedure.
| Group 1 (n = 40) | Group 2 (n = 40) | P value | |
|---|---|---|---|
| Patient movements affecting the procedure | 18 (45.0%) | 2 (5.0%) | <0.001 |
| Hypotension (mean arterial pressure < 60 mm Hg) | 0 (0%) | 0 (0%) | 1.000 |
| Patients requiring ephedrine (systolic blood pressure < 80 mm Hg) | 0 (0%) | 0 (0%) | 1.000 |
| Apnea with desaturation (SpO2 < 90%) | 0 (0%) | 9 (22.5%) | 0.002 |
| Postoperative nausea and vomiting | 0 (0%) | 0 (0%) | 1.000 |
| REMI-induced hyperalgesia | 0 (0%) | 0 (0%) | 1.000 |
Data are shown as number (percentage). Group 1: initial REMI Ce of 1.0 ng/mL; Group 2: initial REMI Ce of 2.0 ng/mL.
Ce = effect-site concentration; REMI = remifentanil, SpO2 = peripheral oxygen saturation.